Literature DB >> 33115918

COVID-19-Associated Acute Kidney Injury: Learning from the First Wave.

Ron Wald1, Sean M Bagshaw2.   

Abstract

Entities:  

Keywords:  COVID-19; acute kidney injury

Mesh：

Year:  2020        PMID： 33115918      PMCID： PMC7894658          DOI： 10.1681/ASN.2020101401

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN： 1046-6673            Impact factor:   10.121


× No keyword cloud information.
  14 in total

1.  COVID-19-Associated Kidney Injury: A Case Series of Kidney Biopsy Findings.

Authors:  Purva Sharma; Nupur N Uppal; Rimda Wanchoo; Hitesh H Shah; Yihe Yang; Rushang Parikh; Yuriy Khanin; Varun Madireddy; Christopher P Larsen; Kenar D Jhaveri; Vanesa Bijol
Journal:  J Am Soc Nephrol       Date:  2020-07-13       Impact factor: 10.121

2.  Acute Start Peritoneal Dialysis during the COVID-19 Pandemic: Outcomes and Experiences.

Authors:  Osama El Shamy; Niralee Patel; Mohamed Halim Abdelbaset; Linda Chenet; Joji Tokita; Robert Lookstein; David S Lee; Noah A Cohen; Shuchita Sharma; Jaime Uribarri
Journal:  J Am Soc Nephrol       Date:  2020-06-16       Impact factor: 10.121

3.  Kidney Biopsy Findings in Patients with COVID-19.

Authors:  Satoru Kudose; Ibrahim Batal; Dominick Santoriello; Katherine Xu; Jonathan Barasch; Yonatan Peleg; Pietro Canetta; Lloyd E Ratner; Maddalena Marasa; Ali G Gharavi; M Barry Stokes; Glen S Markowitz; Vivette D D'Agati
Journal:  J Am Soc Nephrol       Date:  2020-07-17       Impact factor: 10.121

4.  Acute kidney injury in critical ill patients affected by influenza A (H1N1) virus infection.

Authors:  Ignacio Martin-Loeches; Elisabeth Papiol; Alejandro Rodríguez; Emili Diaz; Rafael Zaragoza; Rosa María Granada; Lorenzo Socias; Juan Bonastre; Montserrat Valverdú; Juan Carlos Pozo; Pilar Luque; Jose Antonio Juliá-Narvaéz; Lourdes Cordero; Antonio Albaya; Daniel Serón; Jordi Rello
Journal:  Crit Care       Date:  2011-02-22       Impact factor: 9.097

5.  Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury.

Authors:  Sean M Bagshaw; Ron Wald; Neill K J Adhikari; Rinaldo Bellomo; Bruno R da Costa; Didier Dreyfuss; Bin Du; Martin P Gallagher; Stéphane Gaudry; Eric A Hoste; François Lamontagne; Michael Joannidis; Giovanni Landoni; Kathleen D Liu; Daniel F McAuley; Shay P McGuinness; Javier A Neyra; Alistair D Nichol; Marlies Ostermann; Paul M Palevsky; Ville Pettilä; Jean-Pierre Quenot; Haibo Qiu; Bram Rochwerg; Antoine G Schneider; Orla M Smith; Fernando Thomé; Kevin E Thorpe; Suvi Vaara; Matthew Weir; Amanda Y Wang; Paul Young; Alexander Zarbock
Journal:  N Engl J Med       Date:  2020-07-16       Impact factor: 176.079

6.  Acute Kidney Injury in Coronavirus Disease 2019 Infected Patients: A Meta-Analytic Study.

Authors:  Nicola Brienza; Filomena Puntillo; Stefano Romagnoli; Luigi Tritapepe
Journal:  Blood Purif       Date:  2020-07-02       Impact factor: 2.614

7.  AKI in Hospitalized Patients with COVID-19.

Authors:  Lili Chan; Kumardeep Chaudhary; Aparna Saha; Kinsuk Chauhan; Akhil Vaid; Shan Zhao; Ishan Paranjpe; Sulaiman Somani; Felix Richter; Riccardo Miotto; Anuradha Lala; Arash Kia; Prem Timsina; Li Li; Robert Freeman; Rong Chen; Jagat Narula; Allan C Just; Carol Horowitz; Zahi Fayad; Carlos Cordon-Cardo; Eric Schadt; Matthew A Levin; David L Reich; Valentin Fuster; Barbara Murphy; John C He; Alexander W Charney; Erwin P Böttinger; Benjamin S Glicksberg; Steven G Coca; Girish N Nadkarni
Journal:  J Am Soc Nephrol       Date:  2020-09-03       Impact factor: 10.121

8.  Acute kidney injury among critically ill patients with pandemic H1N1 influenza A in Canada: cohort study.

Authors:  Sean M Bagshaw; Manish M Sood; Jennifer Long; Robert A Fowler; Neill K J Adhikari
Journal:  BMC Nephrol       Date:  2013-06-13       Impact factor: 2.388

Review 9.  The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management.

Authors:  Mouhamed Yazan Abou-Ismail; Akiva Diamond; Sargam Kapoor; Yasmin Arafah; Lalitha Nayak
Journal:  Thromb Res       Date:  2020-06-20       Impact factor: 3.944

10.  Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study.

Authors:  Jianfeng Xie; Wenjuan Wu; Shusheng Li; Yu Hu; Ming Hu; Jinxiu Li; Yi Yang; Tingrong Huang; Kun Zheng; Yishan Wang; Hanyujie Kang; Yingzi Huang; Li Jiang; Wei Zhang; Ming Zhong; Ling Sang; Xia Zheng; Chun Pan; Ruiqiang Zheng; Xuyan Li; Zhaohui Tong; Haibo Qiu; Bin Du
Journal:  Intensive Care Med       Date:  2020-08-20       Impact factor: 17.440
View more
  6 in total

1.  Single-Cell RNA Sequencing of Urinary Cells Reveals Distinct Cellular Diversity in COVID-19-Associated AKI.

Authors:  Matthew D Cheung; Elise N Erman; Shanrun Liu; Nathaniel B Erdmann; Gelare Ghajar-Rahimi; Kyle H Moore; Jeffrey C Edberg; James F George; Anupam Agarwal
Journal:  Kidney360       Date:  2021-11-05

Review 2.  Renal consequences of the novel coronavirus disease 2019 (COVID-19) and hydrogen sulfide as a potential therapy.

Authors:  George J Dugbartey; Karl K Alornyo; Bright O Ohene; Vincent Boima; Sampson Antwi; Alp Sener
Journal:  Nitric Oxide       Date:  2022-01-13       Impact factor: 4.427

3.  Acute kidney injury requiring renal replacement therapy in people with COVID-19 disease in Ontario, Canada: a prospective analysis of risk factors and outcomes.

Authors:  Jian Roushani; Doneal Thomas; Matthew J Oliver; Jane Ip; Yiwen Tang; Angie Yeung; Leena Taji; Rebecca Cooper; Peter O Magner; Amit X Garg; Peter G Blake
Journal:  Clin Kidney J       Date:  2021-11-27

Review 4.  Acute kidney injury and COVID-19.

Authors:  Hayder M Al-Kuraishy; Ali I Al-Gareeb
Journal:  Egypt J Intern Med       Date:  2021-10-06

Review 5.  Regenerative therapy by using mesenchymal stem cells-derived exosomes in COVID-19 treatment. The potential role and underlying mechanisms.

Authors:  Najmeh Kaffash Farkhad; Ali Mahmoudi; Elahe Mahdipour
Journal:  Regen Ther       Date:  2022-03-22       Impact factor: 3.419

6.  Continuous renal replacement therapy versus intermittent hemodialysis as first modality for renal replacement therapy in severe acute kidney injury: a secondary analysis of AKIKI and IDEAL-ICU studies.

Authors:  Jean-Pierre Quenot; Didier Dreyfuss; Stéphane Gaudry; François Grolleau; Saber Barbar; Laurent Martin-Lefevre; Bertrand Pons; Éric Boulet; Alexandre Boyer; Guillaume Chevrel; Florent Montini; Julien Bohe; Julio Badie; Jean-Philippe Rigaud; Christophe Vinsonneau; Raphaël Porcher
Journal:  Crit Care       Date:  2022-04-04       Impact factor: 9.097
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.